Effective treatment of ductal carcinoma in situ with a HER-2-targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer

The standard treatment for ductal carcinoma in situ (DCIS) of the breast is surgical resection, followed by radiation. Here, we tested localized therapy of DCIS in mice using the immunoconjugate (225)Ac linked-trastuzumab delivered through the intraductal (i.duc) route. Trastuzumab targets HER-2/neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Takahiro, Jin, Kideok, Song, Hong, Park, Sunju, Huso, David L., Zhang, Zhe, Liangfeng, Han, Zhu, Charles, Bruchertseifer, Frank, Morgenstern, Alfred, Sgouros, George, Sukumar, Saraswati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078096/
https://www.ncbi.nlm.nih.gov/pubmed/27119227
http://dx.doi.org/10.18632/oncotarget.8949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078096/
https://www.ncbi.nlm.nih.gov/pubmed/27119227
http://dx.doi.org/10.18632/oncotarget.8949

Ejemplares similares